Skip to main content
Complaint Investigation

White Oak Manor - Charlotte

October 27, 2025 · Charlotte, NC · 4009 Craig Avenue
Citations 3
CMS Rating 1/5
Beds 180
Provider ID 345238
Healthcare Facility
White Oak Manor - Charlotte
Charlotte, NC  ·  View full profile →
Source Document
Official CMS Inspection Report (Medicare.gov)
Downloaded from CMS/Medicare.gov. Reflects what state inspectors documented and does not include the facility's plan of correction, which is submitted separately. Facilities may have taken corrective actions since this report was released.
Inspection Summary

White Oak Manor - Charlotte in Charlotte, NC — inspection on October 27, 2025.

Found 3 citations. Severity: Standard violations.

Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.

Inspection Findings

FF0684
Quality of Life and Care Deficiencies

list on the consultation. On 10/01/25, the Licensed Nurse requested an order from the Healthcare

jeopardy to resident health or extremities.

The doppler concluded there was non-occluding thrombus (DVT) identified at the right safety common femoral vein and that the finding could be chronic.

The Licensed Nurse notified the NP, and the NP inquired if Resident #1 was on a blood thinner.

The Licensed Nurse reviewed the chart and

discontinued prior to the suprapubic catheter placement, and it was not restarted after the procedure.

The anticoagulant was then restarted (Eliquis 10mg, every 12 hours x 7 days and then Eliquis 5mg, 1 tablet, every 12 hours). On 10/03/25, Resident #1 was noted to be anxious and vital signs indicated blood pressure 106/60, oxygen saturation 82 % on room air.

New order received from Healthcare Practitioner to administer hydroxyzine (helps to reduce anxiety) 10mg now and to increase oxygen to 3-4 liters per minute via nasal canula. On 10/04/25, the Resident's spouse reported swelling to Resident's left leg which was draining clear liquid, but Resident had no pain or discomfort.

The concern was provided to Healthcare Practitioners to follow up. On 10/07/25, Resident #1 was transferred to the hospital due to being hypoxic with supplemental oxygen and having to wait for a Veteran Affairs (VA) follow-up appointment. Resident #1 was transferred and admitted to acute care hospital.

Hospital records revealed pulmonary embolism, pulmonary artery of the upper and lower lobes necessitating a thrombectomy. On 10/14/25, the Director of Nursing (DON) and the Interim Administrator had an in-person meeting with the Resident's spouse and discussed the concerns regarding the Resident's anticoagulant being held for 85 days.

Formal apology provided on behalf of the facility.

Official grievance was completed and resolved with spouse.

Spouse agreed to allow the Resident to return to the facility. On 10/16/25, Resident readmitted to the facility with an order for anticoagulant (Eliquis 5mg, 1 tablet, every 12 hours). An audit of current residents in the month of October on anticoagulant therapy was completed by running current orders for anticoagulants and reviewing the orders for accuracy to determine whether any changes or adjustments with the anticoagulant were made, and verifying the appropriate administering or discontinuing of the medication as ordered.

The audit was completed by the DON on 10/13/25.

The DON ensured residents had their anticoagulant ordered and administered as required, and verified that the medication was available in the medication cart. No further concerns were identified.

Another audit of current residents on anticoagulant therapy and residents that had discontinued anticoagulant orders for the month of October 2025 was completed on 10/23/25 by the DON and the Assistant Director of Nursing (ADON).

There were no other concerns identified. A further audit will be completed by reviewing the Healthcare Practitioner's progress notes and provider's consultations for the month of October 2025 to identify any other medication that have been discontinued specifically focused on anticoagulant medications and have not been restarted.

The audit will be completed on 10/24/25 by the DON, ADON and the Pharmacy Consultant. If any further concerns are identified from the audit, the Healthcare Practitioner will be notified, and the resident will be evaluated.

Current and newly admitted residents on anticoagulants, residents with newly ordered for anticoagulants and anticoagulant that have been discontinued have the potential to be affected.

The facility will ensure the residents' medications will be administered, discontinued and restarted appropriately.Specify the action the entity will take to alter the process or system failure to prevent a serious adverse outcome from occurring or recurring, and when the action will be complete: The Licensed Nurses were originally re-educated on the importance of ensuring a resident's medication, such as an anticoagulant, that is temporarily discontinued due to a procedure, treatment or hospitalization, has been restarted.

The Licensed Nurse must verify that the medication that the resident was taking prior to being discontinued has been reentered, verified and activated, if still deemed medical necessary. If the medication is held for a certain number of days, the Licensed Nurse is to [TRUNCATED]

345238 10/27/2025

White Oak Manor - Charlotte 4009 Craig Avenue Charlotte, NC 28211

Administration Record).

Refer to the facility's Mediation Administration Record (MAR) for a complete

read ?I have reviewed the resident's medications in the facility chart (MAR) (Medication

and up to date list of active medications.' Resident #1's NP progress note dated 9/30/25 included Eliquis 5 mg oral every 12 hours on the medication list.

The medication list had a statement which read ?I have reviewed the resident's medications in the facility chart (MAR) (Medication Administration Record).

Refer to the facility's Mediation Administration Record (MAR) for a complete and up to date list of active medications.' Resident #1's NP progress note dated 10/01/25 read that the patient's chronic anticoagulation stopped in July 2025 prior to procedure to have suprapubic catheter place.

Anticoagulation was not restarted.

Will reinitiate Eliquis with loading dose. An order to restart the Eliquis was given by telephone from the NP on 10/01/25 at 2:46 PM.

The order was for Eliquis 5 mg 2 tabs (total 10 mg) oral every 12 hours for 7 days, then 5 mg oral every 12 hours with no stop date. An interview on 10/22/25 at 3:51 PM with the NP revealed the progress notes medication list indicated that Eliquis was an active medication for Resident #1.

She stated that the medications carried over from the previous note may not always be accurate or reflect medication changes.

She stated the failure to restart the Eliquis was an oversight. An interview on 10/22/25 at 3:52 PM with the MD revealed Resident #1's Eliquis should have been restarted after the suprapubic catheter insertion procedure.

The medication list on the progress notes were active medications and were carried over from previous progress notes.

The MD stated she reviewed the facility Medication Administration Record for an accurate resident medication list.

The MD was unable to explain how the Eliquis medication was missed and had not been restarted after the urology procedure. An interview on 10/23/25 at 4:18 PM with the Administrator and the Director of Nursing (DON) revealed they were aware the MD and NP progress note medication lists were not always accurate but were unaware of the specific process of how the medication list got on the progress note.

The Administrator stated that the medications should have been reviewed and the failure to restart the Eliquis should have been caught.

345238 10/27/2025

White Oak Manor - Charlotte 4009 Craig Avenue Charlotte, NC 28211

following irregularity reporting guidelines in developed policies and procedures.

record review and interviews with the Consultant Pharmacist, Nurse Practitioner, Medical Director

anticoagulant therapy.

Specifically, Eliquis (an anticoagulant, also known as a blood thinner) was discontinued on 7/2/25 for a surgical procedure and was not resumed until 10/1/25.

This interruption in therapy was not addressed in the drug regimen reviews following the procedure, thereby failing to ensure the continuation of chronic anticoagulant treatment for Resident #1.

This deficient practice was identified in 1 of 3 residents reviewed for unnecessary medications (Resident #1).Findings included:Resident #1 was admitted to the facility on [DATE] with diagnoses which included atrial fibrillation, type 2 diabetes, and a history of pulmonary embolus. On 3/19/25, the physician ordered Eliquis 5 milligrams (mg) by mouth every 12 hours. Resident #1's physician orders for July 2025 revealed Eliquis 5 mg by mouth every 12 hours was discontinued on 7/2/25.

The Consultant Pharmacist review of Resident #1 dated 7/30/25, 8/25/25, and 9/24/25 revealed no recommendations for restarting the Eliquis medication.On 10/1/25 a physician's order was written for 2 Eliquis 5 mg tablet and to administer every 12 hours for total 10 mg.The Consultant Pharmacist was interviewed via phone on 10/23/25 at 9:07 AM. He stated a pharmacy review for Resident #1 was completed on 7/30/25, 8/25/25 and on 9/24/25.

The Consultant Pharmacist stated he did review NP and Medical Director's notes along with labs and it was an oversight that the Eliquis was not included on his July 2025 pharmacy review.

The Consultant Pharmacist stated Eliquis was not on Resident #1's medication list for August 2025 and September 2025 because he knew Eliquis had been stopped by the physician.

The pharmacist stated the Eliquis might have been stopped because of bleeding after the procedure or other reasons, but he did not remember specifics.

The Medical Director was interviewed on 10/23/25 at 12:10 PM and stated the monthly pharmacy reviews should have caught the Eliquis was not restarted and brought it to her attention. An interview on 10/23/25 at 4:18 PM with the Administrator and DON revealed the Eliquis medication should have been reviewed and captured on the pharmacy reviews for Resident #1.

Frequently Asked Questions

What is an F-tag violation?
F-tags are federal deficiency codes used by CMS to categorize nursing home violations. Each F-tag corresponds to a specific federal regulation (42 CFR Part 483). For example, F607 relates to abuse prevention policies, F880 relates to infection control.
Were these violations corrected?
Facilities must submit plans of correction and implement changes within required timeframes. CMS conducts follow-up inspections to verify corrections. Check the inspection report for specific correction dates and follow-up verification status.
How often do nursing home inspections happen?
CMS conducts unannounced inspections of all Medicare/Medicaid-certified nursing homes at least once per year. Additional inspections may occur based on complaints, facility-reported incidents, or follow-up to verify previous violations were corrected.
What should families do about these violations?
Families should: (1) Review the full inspection report for details, (2) Ask facility administration about specific corrective actions taken, (3) Check if this represents a pattern by reviewing prior inspections, (4) Compare with other facilities in Charlotte, NC, (5) Report new concerns to state authorities.
Where can I see the full inspection report?
Complete inspection reports are available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request copies directly from White Oak Manor - Charlotte or from the state Department of Health. Reports include deficiency codes, facility responses, and correction timelines.


More Reports

About This Inspection Report

Source: This inspection report was downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases nursing home inspection reports in bulk. The findings reflect what state surveyors documented in the official Form CMS-2567 Statement of Deficiencies on the date of the inspection.

Plan of correction not included: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to their state survey agency and those responses may not appear in CMS public data at the time of release. The absence of a plan of correction in this report does not mean one was not filed. Readers who want information about corrective steps taken by the facility are encouraged to contact the facility or their state survey agency directly.

Corrections may have been made: This report reflects conditions observed on the date of the survey. The facility may have implemented staffing changes, additional training, policy revisions, or other corrective actions since this report was issued. We publish what CMS provides and encourage readers to seek current information from the facility.